N@N

Facet Biotech Corporation: Facet Biotech Announces Participation at the JMP Securities Research Conference and Webcast on May 1

^{Published on 2009-05-13 13:40:19, Last Modified on 2009-05-13 13:40:43 - Market Wire}
 

REDWOOD CITY, CA--(Marketwire - May 13, 2009) - Facet Biotech Corporation (NASDAQ: [ FACT ]) today announced that the company will participate at the upcoming JMP Securities Research Conference in San Francisco on Tuesday, May 19, 2009 at 10:30 a.m. Pacific Time.

A live webcast of the presentation and the Q&A session will be available through the Facet website at [ www.facetbiotech.com ]. Please connect to this website at least 15 minutes prior to the live webcast to allow time for any software download that may be needed to hear the webcast. A replay will be available at [ www.facetbiotech.com ] starting approximately one hour after completion of the webcast.

About Facet Biotech

Facet Biotech is a biotechnology company dedicated to advancing its pipeline of four clinical-stage products and leveraging its research and development capabilities to identify and develop new oncology drugs. Facet Biotech Corporation launched in December 2008 as a spin-off from PDL BioPharma, Inc.

NOTE: Facet Biotech and the Facet Biotech logo are considered trademarks of Facet Biotech Corporation.